Newest first. 5.2k questions across 107 tags.
Details up front: Changsha · New Zealand. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
For reference: oral semaglutide · ten weeks · 2–8 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
Setup, so nobody has to ask: SSA · CPC · the United States. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
Conditions: ERP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
What I am working with: SURMOUNT-2 · 10 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Two related mechanism questions I have never seen answered together. First, how much of the weight loss is attributable to delayed gastric emptying as opposed to…
What I am working with: SURMOUNT-2 · injection-site erythema. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Setup, so nobody has to ask: aggregation · a GLP-1 receptor agonist · room temperature. I keep seeing this stated as a fact with no explanation attached, and…
What I have: mazdutide · 40 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in…
The case in front of me: SGN · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and…
What I have: 96.4% · a C8 column · tirzepatide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Numbers first: a 29G needle · retatrutide · 5 mg/mL. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
I have kept every message, invoice and document, which I gather is the useful habit. I have the document in front of me and I can read the numbers. What I cannot do…
I have been on a stable schedule for eleven weeks, so this is not a first-week question. I have the document in front of me and I can read the numbers. What I cannot…
The particulars: 96.8% · a wide-pore C18 column · cagrilintide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
The particulars: fatigue · tirzepatide · SURPASS-2. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Transit was eleven days with two scanning gaps, so the thermal history is partly inferred. I would like the arithmetic checked rather than the conclusion asserted. I…
The specifics, since they change the answer: fibrillation · survodutide · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I…
The particulars: GGPeps · Hunan Aslsen Technology. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising…
I have photographs before and after reconstitution if the visual detail matters. The empirical answer seems settled. The explanation does not. If the honest answer is…
Setup, so nobody has to ask: a formic acid mobile phase · mazdutide · a wide-pore C18 column. The empirical answer seems settled. The explanation does not. If the…
The particulars: dulaglutide · three days. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather…
Numbers first: 1.7 mg · sixteen weeks · dizziness. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Details up front: SURPASS-2 · tirzepatide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…